We investigated the effect of alveolysin on human granulocytes. Alveolysin is an exoprotein produced by Bacillus alvei and belongs to the group of sulfhydryl-activated cytolysins. Other members of this group are streptolysin 0 and theta-toxin from Clostridium perfringens. It is demonstrated that alveolysin leads to leukotriene generation from human granulocytes, which exert chemotactic (leukotriene B4) and slowreacting substance (leukotriene C4, D4, and E4) activity under sublytic concentrations.
A wealth of impressive and outstanding biochemical, physiological, and genetic knowledge was obtained in the past decade which provided the basis for understanding the mechanism of pathogenesis of toxin-induced diseases such as diphtheria, cholera, and other diarrheal diseases (1, 3, 13) . Previously it has been reported in a series of papers that the bacterial toxins leukocidin and streptolysin 0 induced as part of their overall cytotoxic effect a noncytotoxic secretion of granule enzymes (34) . We recently presented evidence that the interaction of bacterial toxins such as alpha-toxin, enterotoxin B and lipase from Staphylococcus aureus (14) , and the streptolysin 0 (8, 9) as well as the pseudomonas cytocidin (10, 20) lead to the transformation of arachidonic acid, with the subsequent generation of leukotrienes (6) . Among the lipoxygenase products are factors with a pronounced effect on leukocyte migration and vascular permeability (leukotriene B4 [LTB4]) (5, 15, 17, 28) ; the biological activity referred to for 40 years as slow-reacting substance (SRS) of anaphylaxis consists of three related metabolites of arachidonic acid, LTC4, LTD4, and LTE4 (27) .
Since we had observed that various bacterial exotoxins induce the transformation of arachidonic acid via the lipoxygenase pathway (6), we analyzed the effect of alveolysin on human granulocytes with regard to leukotriene formation. Alveolysin is an exoprotein produced by Bacillus alvei and belongs to the group of thiolsulfhydryl-activated cytolysins (i.e., lethal, cardiotoxic, and membrane-damaging bacterial toxins) which are activated by thiol-containing reagents (1, 21, 31) . Evidence has been provided that, unlike the thiolactivatable toxin streptolysin 0, the alveolysin exerts a different mode of action with cell membranes. Thelestam et al. reported that, unlike streptolysin 0, the toxin did not bind irreversibly to fibroblast cytoplasmic membranes; considerable membrane damage was caused at 0°C as compared with 37°C, and inhibition of amino acid uptake occurred in the absence of significant structural membrane damage (32 Preparation of cells. Human leukocytes were obtained from heparinized blood of healthy donors and separated on a Ficoll-metrizoate gradient, followed by dextran sedimentation. This method leads to more than 97% pure polymorphonuclear leukocytes (PMNs). The cells were then washed at low speed (600 rpm) three times to remove the platelets. Less than 2% of the platelets were detected. Erythrocytes were removed by hypotonic exposure of the cell suspension. As target cells for the chemotactic assay, guinea pig peritoneal cells rich in eosinophils (30 to 80%) were obtained by injecting human serum at weekly intervals intraperitoneally. Neutrophil chemotaxis was carried out with purified human neutrophils (7, 16, 18) .
Buffers. The medium used for washing the cells and for mediator release was, unless otherwise stated, a 0.025 M Tris buffer (pH 7.35) with NaCl (120 mM), KCl (4 mM), CaC12 (0.6 mM) and MgCl2 (1 mM). This is referred to as TCM buffer.
Generation of leukotrienes from human PMNs. Human
PMNs in a volume of 1 ml were incubated with alveolysin (a gift from J. E. Alouf, Institut Pasteur, Paris) at 37°C. For the analysis of chemotactic factor activity, indomethacin (14 ,uM) (Sigma) was added to the incubation mixture to prevent prostaglandin formation. To improve SRS formation and its release from the cells, glutathione (1 mM), CaC12 (2 mM), and cysteine (1 mM) were added to the incubation mixture (12) . After centrifugation of the cells, the supernatant was either assayed for chemotactic and spasmogenic activity or subjected to leukotriene determination by reverse-phase high-pressure liquid chromatography (HPLC). Chemotaxis. The method for eosinophil chemotaxis has been described in detail (7 tion, the cells that had migrated through the filter were counted at lOOx magnification. Five high-power fields were evaluated. Neutrophil chemotaxis was performed with a 3-p.m filter and purified human neutrophils as target cells. The assay conditions were the same as described for the eosinophil chemotaxis. The variation coefficient of the chemotactic assay ranged between 8 and 12%. All chemotactic assays were carried out in five independent determinations performed on different days; each point of the curve represents duplicate or triplicate determinations. Beta-glucuronidase determination was carried out as previously described with phenolphthalein glucuronidate as substrate (11, 16, 18) . Lactate dehydrogenase was measured as previously described (16) .
Measurement of smooth muscle contraction. A 10-ml organ bath was used. The contraction assays were performed on the guinea pig ileum with an isometric device (Hugo Sachs) (6); the isolated guinea pig ileum was treated with mepyramine (1 ,uglml) and atropine (0.2 p.g/ml); acetylcholine 
RESULTS
Induction of chemotactic factor release. Human PMNs (2 x 107/ml) were incubated with various concentrations (0.4 to 400 ng) of alveolysin for 20 min at 37°C. The supernatants were then analyzed for their chemotactic properties towards guinea pig eosinophils and human neutrophils ( Fig. la and  b) . It is apparent that chemotactic activity increased steadily when alveolysin was added to human PMNs at a concentration ranging from 8 to 80 ng. With higher concentrations, chemotactic activity for guinea pig eosinophils decreased. This pattern was different when human granulocytes were used as target cells in the chemotactic assay. It is apparent that increasing concentrations of alveolysin induce higher amounts of chemotactic activity. To exclude cytolytic activity, the release of beta-glucuronidase, a granular and cytoplasmic enzyme marker, was also studied. At the described concentrations, the beta-glucuronidase release amounted to 2.6% at a concentration range of alveolysin which induced optimal eosinophil chemotactic activity (80 ng) and increased up to 11% of the total enzyme content at the highest alveolysin concentration (400 ng) used in our studies (data not shown). Under the experimental conditions, no significant lactate dehydrogenase activity was released. These results clearly suggest that alveolysin induces chemotactic factor generation under sublytic conditions.
The kinetics of chemotactic factor release indicate an optimum after 15 to 20 min of incubation at the three concentrations (40, 80, and 400 ng) of alveolysin studied ( Fig. 2a and b) . In general, a rapid increase in chemotactic activity occurred, which decreased at later times of incubation when guinea pig eosinophils or human neutrophils were used as target cells in the chemotactic assay.
Biological analysis of SRS activity. Experiments were then
carried out to analyze whether alveolysin induces SRS activity from human granulocytes. Human PMNs (2 x 107/ml) were incubated with various concentrations of alveolysin for 20 min at 37°C in the presence of glutathione (1 mM), cysteine (1 mM), and CaCl2 (2 mM). To exclude cyclooxygenase activity, all incubations were performed in the presence of indomethacin (14 ,uM) . It is apparent that higher concentrations of alveolysin induced an increased release in SRS activity, as was determined on the guinea pig ileum (Fig. 3) . As was previously demor bacterial toxins (alpha-toxin, enterotoxin] and the streptolysin 0 as well as the pseudc (6), the alveolysin-induced contractile acti' in the presence of FPL 55 712 (5 x 10-6 M)
Determination of leukotrienes by HPL( data were further supported by HPLC various leukotrienes. Human granulocyte a: with various concentrations of alveolysin in the presence of glutathione, cysteine, and CaCl2, which favor SRS formation. The activity of LTB4 increased starting with an alveolysin concentration of 4 ng, and it reached a maximum with 80 ng. With higher concentrations of alveolysin (400 ng), a decrease in LTB4 release was observed. The release of LTB4 isomers (all-trans isomers), however, increased steadily at the concentrations studied in the cell supernatants. LTC4 and LTD4 activities were demonstrated beginning at alveolysin concentrations of 0.4 and 4 ng, respectively. LTC4 activity increased steadily with higher concentrations of alveolysin, whereas LTD4 activity showed a sharp decline at a concentration of 400 ng (Table 1) . Further support for LTC4 and LTD4 generation was recently obtained by radioimmunoassay (data not shown; manuscript in preparation).
DISCUSSION istrated for other
Our data indicate that alveolysin interacts with human B from S. aureus, granulocytes and leads to leukotriene generation, as was Dmonas cytocidin) assessed by chemotaxis and smooth muscle contraction on vity was inhibited the terminal guinea pig ileum. The chemotactic pattern (data not shown).
demonstrated by eosinophil chemotaxis contrasts to that C. The biological shown with human neutrophils. Concentrations above 100 analysis for the ng led to a striking decrease of chemotactic factor activity s were incubated for guinea pig eosinophils, whereas with human neutrophils as target cells, concentrations higher than 100 ng increased the chemotactic response ( Fig. la and b) . When this pattern was compared with the biochemical analysis of LTB4, concentrations higher than 100 ng also led to a significant decrease in LTB4 activity, whereas LTB4 isomers, which are 10-to 100-fold less active than LTB4, revealed a plateau (Table 1) . These results could be due to the fact that eosinophils and neutrophils differ in their sensitivity towards the leukotrienes and isomers; also, monohydroxylated eicosatetraenoic acids (e.g., 5-or 15-HETE) which were not determined could contribute to the chemotactic responsiveness of the neutrophils to a greater extent than the guinea pig eosinophils. Thus, we cannot exclude at present the possibilx ity that the chemotactic responses reflect the fact that the dose dependence of formation of the various arachidonic acid metabolites is different, producing varying results of multiple variables; i.e., the amount of LTB4 generated may not correlate exactly with the biological data obtained by chemotaxis ( Fig. 2a and b (Table 1) . One might speculate that a gamma-glutamyltranspeptidase induces the transformation from LTC4 to LTD4 at concentrations between 8 and 80 ng of alveolysin per ml. The subsequent decrease in LTD4 activity might be due to the interaction of a cellular dipeptidase which transforms LTD4 to LTE4.
It is by now clearly established that among the lipoxygenase factors the leukotrienes are the most effective mediators with regard to their ability to increase vascular permeability, to induce chemotaxis and chemoaggregation (LTB4) (2, 5, 22, 28) , and to initiate spasmogenic activity (SRS of anaphylaxis, LTC4, LTD4, and LTE4). In the past, numerous reports have dealt with the various mechanisms of cell activation leading to the release of these newly generated mediators of inflammation (19, 24, 25) . Among the stimuli which have been described are the calcium ionophore A 23 187 (7), phagocytosis (16), the anaphylatoxins (23), the platelet-activating factor (25) , immunoglobulin E immune complexes (26) , and the bee venom peptide melittin (17); cells which have been shown to release leukotrienes are mast cells, basophils, polymorphonuclear granulocytes, mononuclear cells, macrophages (peritoneal, alveolar), and rat basophilic leukemia cells. Quite recently it has been shown that leukotriene antagonists prevent endotoxin lethality in sensitized mice (11) . The fact that defined bacterial exotoxins induce leukotriene formation could be responsible for many symptoms which evolve during bacterial infection. Furthermore, this model provides new perspectives to analyze membrane-activating steps in the course of adhesiveness of bacteria (33) and after toxin-receptor interactions with various cells.
